Skip to main content

Table 3 Interaction between circRNAs and K-RAS in the context of cancer (ANTs: adjacent normal tissues)

From: Emerging role of non-coding RNAs in the regulation of KRAS

circRNAs

Diseases

Pattern of expression

Samples

Cell lines

Targets/regulators

Signaling pathways

Function

References

FAT1; HIPK3; ARHGAP; MAN1A2; RHOBTB3; RTN4; SMARCA5

Colon cancer

Down

–

DLD-1, DKO-1 cells, DKs-8 cells

KRAS

–

circRNAs may serve as promising cancer biomarkers

[74]

circITGA7

Colorectal cancer

Down

69 pairs of colorectal cancer samples and ANTs

s (SW480, RKO, Caco-2, SW620, LoVo, HCT116 and DLD1

ITGA7

Ras pathway

circITGA7 represses the proliferation and metastasis of CRC cells via inhibiting the Ras signaling pathway and inducing the transcription of ITGA7

[73]

Circ_GLG1

Colorectal cancer

Up

40 pairs of CRC tissues and ANTs

HCT116, SW620, and DLD1 cells

miR-622

Ras pathway

circ_GLG1 promoted tumor cell viability, proliferation, invasion, and migration

[72]

circFNTA

Bladder cancer

Up

41 cancer tissues and matched ANTs

SVHUC, BCa cell lines T24, J82, 5637, and UMUC3

miR-370-3p

Ras pathway

circFNTA induced cell invasion and cisplatin chemo-resistance

[75]

Circ-MEMO1

Non-small cell lung cancer

Up

52 pairs of SCLC tissue samples and ANTs

H1650, PC9, H1299, and A549

miR-101-3p

miR-101-3p/KRAS Axis

Circ-MEMO1 induced the progression and aerobic glycolysis of lung cancer cells

[76]